New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules - Hardcover

 
9780792387145: New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules

Synopsis

volume of conference proceedings reviews the general pathophysiological significance of the isoforms of cyclooxygenase, and the likely value of selective COX-2 inhibitors in the treatment of rheumatoid conditions. Also covered is the possible use of antibodies against cytokines and cell adhesion receptors in the treatment of inflammatory conditions.

"synopsis" may belong to another edition of this title.

About the Author

Jack Botting is Consultant at the William Harvey Research Institute, an independent charitable foundation within Queen Mary and Westfield College of the University of London, UK. Sir John Vane is the Director General at the William Harvey Research Institute, an independent charitable foundation within Queen Mary and Westfield College of the University of London, UK.
Sir John Vane shared the Nobel Prize in Physiology or Medicine in 1982 for his discoveries of the mechanism of action of aspirin and of prostacyclin, as well as his work on other prostanoids.

"About this title" may belong to another edition of this title.

Other Popular Editions of the Same Title

9789401062657: New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules Proceedings of a conference held on April 15–16, 1996, in New Orleans, USA, ... educational grant from Boehringer Ingelheim

Featured Edition

ISBN 10:  940106265X ISBN 13:  9789401062657
Publisher: Springer, 2012
Softcover